Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.64, $0.39 better than the analyst estimate of $1.25. Revenue for the quarter came in at $695.8 million versus the consensus estimate of $595.88 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.